CEPI funds trials against emerging infectious disease
With many organizations pivoting to work on the pandemic, CEPI partners with consortium to develop a vaccine against the Chikungunya virus.
With many organizations pivoting to work on the pandemic, CEPI partners with consortium to develop a vaccine against the Chikungunya virus.
A law firm investigates Inovio over claims it developed a vaccine to COVID-19 within three hours.
The company announces a shipping unit for the temperature-controlled delivery of cell therapies and cryopreserved apheresis.